https://www.aidsmap.com/news/feb-2016/new-merck-combination-pill-zepatier-approved-hepatitis-c-treatment-united-states
Merck has received a US license for its direct-acting antiviral combination of grazoprevir and elbasvir, to be marketed as Zepatier. The combination of...
hepatitis c treatmentnewmerckcombinationpill